MAM
NMTR

Meeder Asset Management’s 9 Meters Biopharma NMTR Stock Holding History

Meeder Asset Management’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-75
Closed -$2K – 2303
2019
Q2 		$2K Buy
75
+37
+97% +$1.11K ﹤0.01% 1898
2019
Q1 		$1K Sell
38
-91
-71% -$3.94K ﹤0.01% 1657
2018
Q4 		$6K Buy
129
+80
+163% +$5.93K ﹤0.01% 1382
2018
Q3 		$6K Buy
49
+37
+308% +$6.36K ﹤0.01% 1306
2018
Q2 		$5.75K Buy
+12
New +$4.42K ﹤0.01% 1243

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return
SXL
Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Meeder Asset Management's NMTR Position: Q3 2019 in Review

Meeder Asset Management sold out of 9 Meters Biopharma (NMTR) in Q3 2019, closing a stake of 75 shares — an estimated $2K sold.

Meeder Asset Management first reported a position in NMTR in Q2 2018 and held it in 5 quarters. The position peaked at $6K in Q4 2018. 19 funds tracked by Wall St. Rank hold NMTR as of Q3 2019.

  • Meeder Asset Management reported no remaining 9 Meters Biopharma position as of Q3 2019 after selling out during the quarter.
  • Meeder Asset Management sold 75 9 Meters Biopharma shares in Q3 2019, an estimated $2K.
  • Meeder Asset Management first reported a position in 9 Meters Biopharma in Q2 2018 and held it in 5 quarters.
  • Meeder Asset Management's 9 Meters Biopharma position peaked at $6K in Q4 2018.
  • 19 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2019.

Based on Meeder Asset Management's 13F filing for Q3 2019, filed 17 Oct 2019.